Current State Assessment
Capability assessment establishes what exists and what works, since strategies built on an inaccurate current state fail at first contact with delivery.
Most healthcare IT strategies fail on capacity rather than direction. A three-year roadmap describing twelve initiatives against a team that can deliver four will complete four of them, and which four gets decided by whoever escalates most effectively rather than by the strategy. Sequencing against real delivery capacity is what turns a roadmap into a plan.
Health organizations carry accumulated systems, competing priorities, and clinical constituencies who can stop anything. Taction Software delivers healthcare IT strategy consulting that produces sequenced plans grounded in what an organization can actually execute.

Our experts are ready to understand your business goals.






























































Healthcare IT strategy consulting covers technology direction for health organizations: current state capability assessment, application portfolio rationalization, EHR and clinical platform strategy, data and analytics architecture direction, investment sequencing, delivery capacity assessment, and governance structures supporting execution. The output is a sequenced plan rather than an aspirational document. Our work sits within our broader healthcare software development practice.
Capability assessment establishes what exists and what works, since strategies built on an inaccurate current state fail at first contact with delivery.
Portfolio review identifies redundant and unsupported systems, which accumulate in health organizations through acquisition and departmental purchasing.
EHR direction addresses modernization and consolidation, which dominates investment capacity when it is in scope for a period.
Data architecture strategy connects with our healthcare data warehouse practice on foundations analytics depends on.
Capacity realism establishes what the organization can execute, which constrains the roadmap more than budget usually does.
Sequencing orders initiatives by dependency and capacity rather than by stakeholder enthusiasm, which is how roadmaps become deliverable.
Our healthcare IT strategy consulting services cover assessment, portfolio analysis, platform strategy, roadmap development, and governance design. The conversation that determines whether a strategy survives is delivery capacity, since organizations consistently plan more than they can execute and then attribute the shortfall to prioritization failure rather than to arithmetic. Engagements typically open by establishing historical delivery throughput.
Assessment establishes actual system and capability position, testing documentation against operational reality rather than accepting it.
Application review identifies consolidation opportunity, though we are realistic that decommissioning is harder politically than technically.
Clinical and core platform direction addresses the decisions that consume most investment capacity when they are in play.
Delivery history establishes realistic throughput, since past performance predicts future capacity better than organizational intentions do.
Sequenced planning orders work by dependency and capacity, producing a plan that can be executed rather than a list of intentions.
Decision structures support execution, connecting with our healthcare IT governance work.
The benefits concentrate in executable plans, rationalized investment, and defensible prioritization. Strategies that exceed capacity produce the same outcome as no strategy, since actual sequencing then happens through escalation. We publish no figures on cost reduction, efficiency, or delivery improvement, because those depend entirely on starting position and organizational execution.
Capacity-grounded roadmaps produce plans that survive contact with delivery, rather than intention lists that reprioritize through escalation.
Application consolidation reduces maintenance burden, though the constraint is usually organizational rather than technical.
Dependency-based sequencing gives leadership a rationale for saying no, which is the scarcest capability in most IT organizations.
Clinical platform strategy settles the decisions that otherwise consume years of unresolved debate and blocked adjacent work.
Capacity alignment matches investment to what can be absorbed, since funding beyond delivery capacity produces spending rather than outcomes.
Decision rights reduce the escalation-driven reprioritization that undermines any sequencing a strategy establishes.
We deliver healthcare IT strategy consulting in phases so executive, clinical, and IT stakeholders approve direction before planning completes. Discovery establishes delivery throughput from history, which frequently produces an uncomfortable conversation about how much the organization can genuinely execute. We would rather have that conversation during planning than watch a roadmap fail across two years.
Discovery establishes historical delivery throughput, since it predicts capacity more reliably than organizational ambition or stated intent.
Capability review tests documentation against operational reality, since system inventories in health organizations are routinely incomplete.
Priority gathering covers clinical, operational, and executive stakeholders, since a strategy without clinical support will be blocked regardless of merit.
Rationalization and platform work identifies consolidation and modernization opportunity with realistic assessment of organizational difficulty.
Sequencing builds a plan within capacity, explicitly identifying what is deferred rather than leaving everything nominally in scope.
Decision structures are designed to hold sequencing under pressure, with handoff to the team executing.
IT strategy engagements involve access to system documentation, architecture, and organizational information rather than patient data in most cases. Taction holds ISO 27001 certification and follows HIPAA-aligned engineering practice. Strategy work should account for regulatory obligations as constraints on sequencing, since compliance-driven work frequently cannot be deferred in favor of initiatives with better business cases.
Compliance obligations constrain sequencing, since regulatory work cannot be deferred for initiatives with stronger business cases.
Clinical support determines feasibility, since clinical stakeholders can stop initiatives regardless of executive sponsorship or business case.
Security investment is treated as a constraint rather than a competing priority, connecting with our HIPAA compliance software development practice.
Assessment access covers architecture and documentation, avoiding patient data where strategy questions do not require it.
Platform dependency affects strategic flexibility, which strategies frequently understate when a core vendor constrains realistic options.
Strategy findings including capability gaps are handled with appropriate confidentiality, since candid assessment is only useful if it can be candid.
Taction Software was founded in 2013 and has spent over 12 years building healthcare software, delivering more than 200 healthcare projects from four US offices in Chicago, Cheyenne, Austin, and Sacramento, with ISO 27001 certification. Our relevant discipline is grounding roadmaps in delivery capacity, which usually means recommending a smaller plan than the organization expected. A four-initiative roadmap that completes beats a twelve-initiative roadmap that does not. Our leadership brings more than 20 years of personal experience in the field.
We size roadmaps to delivery throughput, which usually means recommending less than the organization planned and more than it will complete otherwise.
We name what is not being done, since leaving everything nominally in scope is how sequencing collapses into escalation-driven reprioritization.
We build healthcare software ourselves, so estimates and sequencing reflect what execution involves rather than framework assumptions.
Founded in 2013, we have concentrated on healthcare rather than treating it as one vertical among several, producing depth in clinical systems.
We assess clinical acceptance, since initiatives clinical stakeholders oppose do not complete regardless of executive sponsorship.
ISO 27001 certification means security controls are documented and auditable, supporting your vendor assessment efficiently.
Healthcare IT strategy consulting pricing depends on organizational scale, assessment depth, stakeholder count, and whether governance design is included. Assessment depth is the main variable, since testing documented state against operational reality takes considerably longer than reviewing documentation. Discovery produces an itemized, fixed-scope estimate with phase-level breakdown. Travel and third-party assessment costs are separate and itemized clearly.
A focused engagement covering assessment and roadmap for a defined scope typically runs $40,000 to $80,000.
A full strategy engagement with portfolio rationalization and governance design typically falls between $80,000 and $200,000.
Enterprise engagements covering health system scale and multi-entity portfolios start at $200,000.
Discovery is a paid, time-boxed phase producing an itemized estimate, engagement plan, and throughput baseline.
Assessment depth, organizational scale, stakeholder count, and governance scope are the largest variables, identified during discovery.
Roadmap maintenance and advisory support are quoted separately, since strategy requires revisiting as capacity and priorities change.
If you are evaluating healthcare IT strategy consulting for roadmap development, portfolio rationalization, or platform direction, the fastest next step is a discovery call with our team. We will establish delivery throughput and assessment scope, then return an itemized, fixed-scope estimate. Contact us to schedule that conversation.
Executive and IT leaders evaluating healthcare IT strategy consulting usually ask why strategies fail, how capacity is assessed, and whether a roadmap survives contact with operations. The answers below reflect how we scope these engagements.
Capacity rather than direction, in most cases. Organizations plan more than they can deliver, then reprioritize through escalation, which means the loudest stakeholder effectively sets the sequence. The strategy document remains accurate and irrelevant.
From historical throughput rather than stated intent. What an organization delivered over the prior two years predicts the next two more reliably than any plan, and the gap between that figure and a proposed roadmap is usually the most useful finding in the engagement.
Only with governance that holds sequencing under pressure. A plan without decision rights reverts to escalation-driven prioritization within months, which is why governance design is part of the work rather than a separate engagement.
A focused engagement runs $40,000 to $80,000. A full strategy engagement typically falls between $80,000 and $200,000. Enterprise health system engagements start at $200,000. Assessment depth drives cost most.
Rarely, and only where the analysis genuinely supports it. Clinical platform replacement consumes years of capacity and carries clinical disruption that frequently outweighs the benefit. We would rather find what else is possible within the existing platform.
Then it will not happen, and the strategy should account for that rather than assuming executive sponsorship overcomes it. Clinical feasibility is assessed during planning, since initiatives clinicians oppose fail slowly and expensively rather than being cancelled cleanly.
Your email address will not be published. Required fields are marked *
Our expert reaches out shortly after receiving your request and analyzing your requirements.
If needed, we sign an NDA to protect your privacy.
We request additional information to better understand and analyze your project.
We schedule a call to discuss your project, goals. and priorities, and provide preliminary feedback.
If you're satisfied, we finalize the agreement and start your project.